AstraZeneca signs $2 billion deal for autoimmune diseases
HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to
HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to
HQ Team June 9, 2023: Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and
HQ Team June 8, 2023: The COVID-19 virus can fuse the brain cells that may lead to disruption in cell-to-cell communication resulting in
HQ Team June 8, 2023: Peanut allergy is a serious health concern and nearly 2 per cent of the Western population suffers from
HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the
HQ Team June 7, 2023: A team of researchers at George Washington University has developed an ingestible pill camera that can be “driven”
HQ Team June 7, 2023: Vitamins supplements have become a routine part of our health regime and since these pills are not as
HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for